Berezin M, Gutman I, Tadmor R, Horowitz A, Findler G
Institute of Endocrinology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Acta Endocrinol (Copenh). 1992 Nov;127(5):476-80. doi: 10.1530/acta.0.1270476.
Malignant prolactinoma is a rare entity and only a few cases have been published. The diagnostic criteria and the clinical course remain unclear. We present a case of malignant prolactinoma in a woman with a 30-year duration of the disease. In the terminal stage of the disease the prolactinoma metastasized to the left eye, the prolactin level reaching 196000 mU/l. Bromocriptine in high doses was not effective. The response to pergolide was good in the first two years of treatment; thereafter an escape effect was observed. The patient died in a comatose state. A review of previously published cases follows.